These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Exploring the relationship among ADHD, stimulants, and substance abuse. Nelson A; Galon P J Child Adolesc Psychiatr Nurs; 2012 Aug; 25(3):113-8. PubMed ID: 22830508 [TBL] [Abstract][Full Text] [Related]
44. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. Levin FR J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376 [TBL] [Abstract][Full Text] [Related]
45. [The course of attention deficit hyperactivity disorder (ADHD) over the life span]. Koumoula A Psychiatriki; 2012 Jun; 23 Suppl 1():49-59. PubMed ID: 22796973 [TBL] [Abstract][Full Text] [Related]
46. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325 [TBL] [Abstract][Full Text] [Related]
47. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment]. Paslakis G; Schredl M; Alm B; Sobanski E Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520 [TBL] [Abstract][Full Text] [Related]
48. Stimulant treatment of ADHD and risk of sudden death in children. Vitiello B; Towbin K Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196 [No Abstract] [Full Text] [Related]
49. Managing attention-deficit/hyperactivity disorder in children and adolescents. McClain EK; Burks EJ Prim Care; 2015 Mar; 42(1):99-112. PubMed ID: 25634708 [TBL] [Abstract][Full Text] [Related]
51. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988 [TBL] [Abstract][Full Text] [Related]
52. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View. Maremmani I; Spera V; Maiello M; Maremmani AGI; Perugi G Curr Top Behav Neurosci; 2022; 57():179-198. PubMed ID: 35507285 [TBL] [Abstract][Full Text] [Related]
53. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Pliszka SR Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655 [TBL] [Abstract][Full Text] [Related]
54. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I. Merkel RL; Kuchibhatla A Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509 [TBL] [Abstract][Full Text] [Related]
55. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [TBL] [Abstract][Full Text] [Related]
56. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. Pliszka SR J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053 [TBL] [Abstract][Full Text] [Related]
59. Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder? Kaye S; Darke S; Torok M Addiction; 2013 May; 108(5):923-31. PubMed ID: 23227816 [TBL] [Abstract][Full Text] [Related]
60. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration? Looby A Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]